Prof Obermair’s research interests are driven by patients’ needs and include less invasive treatments with better recovery that are equally effective. His main effort focuses on assembling a world-class team to conduct clinical trials that change the treatment of women affected by gynaecological cancer for the better. As the Director of Research at the Queensland Centre for Gynaecological Cancer Prof Obermair leads a team of up to 20 researchers. Prof Obermair also collaborates with researchers within Gynaecological Oncology units in Australia and the United States of America, Asia and Europe. He has authored more than 250 research articles in scientific journals.
Some of his latest publications include:
Quality of life in patients with cervical cancer after open versus minimally invasive radical hysterectomy (LACC): a secondary outcome of a multicentre, randomised, open-label, phase 3, non-inferiority trial. (2020) The Lancet Oncology
Fertility-sparing treatment in early endometrial cancer: current state and future strategies (2020) Obstetrics & Gynecology Science.
Quality of life following minimally invasive hysterectomy compared to abdominal hysterectomy: A metanalysis (2020) European Journal of Obstetrics and Gynecology and Reproductive Biology.
Surgical approach to hysterectomy and barriers to using minimally invasive methods (2018) Australian and New Zealand Journal of Obstetrics and Gynaecology.
Effect of Total Laparoscopic Hysterectomy vs Total Abdominal Hysterectomy on Disease-Free Survival Among Women With Stage I Endometrial Cancer: A Randomized Clinical Trial (2017) Journal of the American Medical Association (JAMA).
See Prof Obermair’s full list of publications